Analysis of high‐throughput sequencing data from osteosarcoma patients in the GEO and TARGET‐OS datasets revealed significantly elevated ATP1A1 expression in tumor tissues, particularly among patients with poor clinical outcomes. This evidence concerns the gene ATP1A1 and neoplasm.